Display options
Cite
Abazid RM, Romsa JG, Warrington JC, et al. Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis. J Nucl Cardiol. 2021;doi: 10.1007/s12350-020-02508-3.
Abazid, R. M., Romsa, J. G., Warrington, J. C., Stodilka, R. Z., Davey, R. A., De, S., Laidley, D. L., Vezina, W. C., & Akincioglu, C. (2021). Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, . https://doi.org/10.1007/s12350-020-02508-3
Abazid, Rami M, et al. "Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. (2021). doi: https://doi.org/10.1007/s12350-020-02508-3
Abazid RM, Romsa JG, Warrington JC, Stodilka RZ, Davey RA, De S, Laidley DL, Vezina WC, Akincioglu C. Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis. J Nucl Cardiol. 2021 Jan 27; doi: 10.1007/s12350-020-02508-3. Epub 2021 Jan 27. PMID: 33502692.
Copy Download .nbib Format: NLM
Share it on

J Nucl Cardiol. 2021 Jan 27; doi: 10.1007/s12350-020-02508-3. Epub 2021 Jan 27.

Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Rami M Abazid, Jonathan G Romsa, James C Warrington, Robert Z Stodilka, Ryan A Davey, Sabe De, David L Laidley, William C Vezina, Cigdem Akincioglu

Affiliations

  1. Division of Nuclear Medicine, London Health Sciences Centre, University Hospital, 339 Windermere Road, PO Box 5010, London, ON, N6A 5A5, Canada. [email protected].
  2. Division of Nuclear Medicine, London Health Sciences Centre, University Hospital, 339 Windermere Road, PO Box 5010, London, ON, N6A 5A5, Canada.
  3. Division of Cardiology, London Health Sciences Centre, University Hospital, 339 Windermere Road, PO Box 5010, London, ON, N6A 5A5, Canada.

PMID: 33502692 DOI: 10.1007/s12350-020-02508-3

[No abstract available.]

References

  1. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 2019;26:2065-123. https://doi.org/10.1007/s12350-019-01760-6 . - PubMed
  2. Longhi S, Quarta CC, Milandri A, Lorenzini M, Gagliardi C, Manuzzi L et al. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role. Amyloid 2015;22:147-55. https://doi.org/10.3109/13506129.2015.1028616 . - PubMed

Publication Types